El creador de una vacuna rusa contra el COVID-19 aseguró el miércoles que esta tiene una eficacia del 92%, días después de que el estadounidense Pfizer y el alemán BioNTech anunciaran que la que están desarrollando ellos es eficaz en un 90%. (Fuente: AFP)
:quality(75)/cdn.jwplayer.com/v2/media/LIy1dI2W/poster.jpg)
:quality(75)/dvgnzpfv30f28.cloudfront.net/11-11-2020/t_e6471e89b61d45fe9d9850ab0562d868_name_file_640x360_600_v3_.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/75T3paxO/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6V1J37vO/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5LW5P4LZHKLCXFJFBTPRMFZQ.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/s0C6EY3S/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Fp4txKkv/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/0Iveihj3/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/WJ7ovIRU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/t8AjJvjZ/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZJRMYQTLGVFTTCQZDWD6JUNJ34.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XLIWX6IVYFA63APPYFLFMQREXI.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/OEOX64ECKFBR5H3UAOANUZ3Q2E.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/75T3paxO/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6V1J37vO/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5LW5P4LZHKLCXFJFBTPRMFZQ.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/5h1UIiRn/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GEQ7WQKQH5AKHKPKX3Y6S7JWPI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Q5IHQ7WO6RGCHB35PGTKDFMWHQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZOUZQFL2UZEO5LWZUPKIPD7LHQ.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/VNBRMI43GNDOPLZ5YTIZLUGJUE.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/wXUo9jVU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nu9nKgwG/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GCHGHNUMHVAIDBFA2VHOVRIAMY.png)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/LIy1dI2W/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Xv8iJGpA/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/EXTCEP2GUBC7XBDWQE34RG4BO4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/DOIUFLVUQ5AJDN2ZVTQQC7KHZ4.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)